Guy Leclerc

Dr. Guy Leclerc is an interventional cardiologist, entrepreneur, and philanthropist affiliated with the Université de Montréal (UdeM) and the Centre Hospitalier de l'Université de Montréal (CHUM). He completed his MD in 1983 and cardiology specialization in 1989 from UdeM's Faculty of Medicine. His career spans academic research, medical innovation, and business leadership, including heading CHUM's Department of Cardiology and Cardiac Surgery and founding companies like Angiogène and AccelLab. He has pioneered translational research in medical devices such as stents, valves, and pacemakers.

Education:

• MD, Université de Montréal (1983)
• Cardiology Specialization, Université de Montréal (1989)
• Postdoctoral studies, Boston

Research & Innovation: Leclerc established a molecular cardiology laboratory at Notre-Dame Hospital with MRCC funding. He patented medical technologies, raised $6M through business partnerships, and founded AccelLab (2004), which grew to 115 employees and $16M in revenue before its sale in 2019. His work focuses on advancing interventional cardiology through medical device development and translational research.

Grants & Philanthropy: Secured grants from the Medical Research Council of Canada (MRCC) for his molecular cardiology lab. Committed to giving back, he supports CHUM to improve healthcare in Quebec through discreet philanthropy.

Labs & Ventures: Molecular Cardiology Lab (Notre-Dame Hospital), AccelLab (medical product R&D), and Angiogène (cardiovascular innovations).